The Role of Robotics in India’s Surgical Device Market
India’s surgical device market is experiencing a transformative shift with the integration of robotics, enhancing surgical precision, reducing patient recovery times, and expanding the range of minimally invasive procedures.
Market Growth and Adoption:
- Rapid Expansion: The Indian surgical robotics market was valued at approximately USD 851 million in FY2023 and is projected to reach USD 3,733 million by FY2031, growing at a compound annual growth rate (CAGR) of 20.3% between FY2024 and FY2031.
- Increasing Installations: As of 2021, India had nearly 76 fully functional surgical robots, with over 500 surgeons trained in robotic-assisted procedures.
Key Developments:
- SSI Mantra: Developed by SS Innovations, the SSI Mantra is India’s first indigenously produced surgical robot, offering a cost-effective alternative to imported systems. Priced at approximately ₹5 crore, it is significantly more affordable than comparable international models, which can cost around ₹15 crore.
- MISSO Robotic System: Launched by Meril, the MISSO system is designed for knee replacement surgeries and is fully developed and manufactured in India, costing nearly 66% less than existing systems.
Impact on Healthcare:
- Enhanced Precision: Robotic systems provide surgeons with improved control and accuracy, leading to better patient outcomes and reduced complication rates.
- Minimally Invasive Procedures: The adoption of robotic surgery facilitates minimally invasive techniques, resulting in smaller incisions, reduced scarring, and faster recovery times for patients.
Challenges and Considerations:
- High Costs: Despite advancements, the high cost of robotic surgical systems remains a barrier to widespread adoption, particularly in smaller healthcare facilities.
- Training and Expertise: There is a need for standardized training programs to ensure surgeons are proficient in using robotic systems, which is essential for maximizing their benefits.
